BRPI1011522A2 - compostos de indol substituídos como moduladores receptor de bradiquinina 1. - Google Patents
compostos de indol substituídos como moduladores receptor de bradiquinina 1.Info
- Publication number
- BRPI1011522A2 BRPI1011522A2 BRPI1011522A BRPI1011522A BRPI1011522A2 BR PI1011522 A2 BRPI1011522 A2 BR PI1011522A2 BR PI1011522 A BRPI1011522 A BR PI1011522A BR PI1011522 A BRPI1011522 A BR PI1011522A BR PI1011522 A2 BRPI1011522 A2 BR PI1011522A2
- Authority
- BR
- Brazil
- Prior art keywords
- receptor modulators
- substituted indole
- indole compounds
- bradykinin receptor
- bradykinin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09001488 | 2009-02-04 | ||
PCT/EP2010/000630 WO2010089084A1 (de) | 2009-02-04 | 2010-02-02 | Substituierte indol-verbindungen als bradykinin rezeptor 1 modulatoren |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1011522A2 true BRPI1011522A2 (pt) | 2016-03-29 |
Family
ID=40839539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1011522A BRPI1011522A2 (pt) | 2009-02-04 | 2010-02-02 | compostos de indol substituídos como moduladores receptor de bradiquinina 1. |
Country Status (10)
Country | Link |
---|---|
US (1) | US8492559B2 (pt) |
EP (1) | EP2393803A1 (pt) |
JP (1) | JP2012516860A (pt) |
AR (1) | AR074967A1 (pt) |
AU (1) | AU2010211251A1 (pt) |
BR (1) | BRPI1011522A2 (pt) |
CA (1) | CA2751402A1 (pt) |
MX (1) | MX2011008126A (pt) |
TW (1) | TW201031665A (pt) |
WO (1) | WO2010089084A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102069913B1 (ko) | 2012-03-16 | 2020-01-23 | 비타이 파마슈티컬즈, 엘엘씨 | 간 x 수용체 조절제 |
ES2598653T3 (es) | 2012-03-16 | 2017-01-30 | Vitae Pharmaceuticals, Inc. | Moduladores del receptor X del hígado |
CN104945416B (zh) * | 2014-03-24 | 2017-11-17 | 中国科学院上海药物研究所 | 一类螺异噁唑啉衍生物、其制备方法及医药用途 |
CN112573978B (zh) * | 2019-09-30 | 2022-05-13 | 北京大学 | 一种芳基卤化物的高效卤化合成方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6147106A (en) * | 1997-08-20 | 2000-11-14 | Sugen, Inc. | Indolinone combinatorial libraries and related products and methods for the treatment of disease |
EP1165518A2 (en) * | 1999-04-02 | 2002-01-02 | Neurogen Corporation | Benzimidazole and imidazolopyridine derivatives, their preparation and their use as selective modulators of bradykinin b2 (= bk-2) receptors |
GB0017256D0 (en) | 2000-07-13 | 2000-08-30 | Merck Sharp & Dohme | Therapeutic agents |
WO2004022056A1 (ja) * | 2002-09-06 | 2004-03-18 | D. Western Therapeutics Institute | 悪性腫瘍を処置するための医薬組成物、方法および使用 |
EP1600447A1 (en) | 2004-05-28 | 2005-11-30 | Neuropharma S.A.U. | Butyrylcholinesterase selective inhibitors |
US20060128765A1 (en) * | 2004-12-10 | 2006-06-15 | Wood Michael R | 2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation |
WO2007101007A2 (en) | 2006-02-23 | 2007-09-07 | Neurogen Corporation | Aryl sulfonyl heterocycles |
WO2007140383A2 (en) | 2006-05-30 | 2007-12-06 | Neurogen Corporation | Spirocyclic sulfonamides and related compounds |
WO2008033739A2 (en) * | 2006-09-12 | 2008-03-20 | Neurogen Corporation | Benzimidazole carboxamide derivatives |
SI2066659T1 (sl) | 2006-09-29 | 2013-10-30 | Grunenthal Gmbh | Substituirani sulfonamidni derivati |
WO2008046573A1 (de) | 2006-10-16 | 2008-04-24 | Grünenthal GmbH | Substituierte sulfonamid-derivate als bradykinin 1 rezeptor modulatoren |
-
2010
- 2010-01-15 TW TW099101012A patent/TW201031665A/zh unknown
- 2010-01-29 AR ARP100100246A patent/AR074967A1/es not_active Application Discontinuation
- 2010-02-02 EP EP10703016A patent/EP2393803A1/de not_active Withdrawn
- 2010-02-02 WO PCT/EP2010/000630 patent/WO2010089084A1/de active Application Filing
- 2010-02-02 BR BRPI1011522A patent/BRPI1011522A2/pt not_active IP Right Cessation
- 2010-02-02 AU AU2010211251A patent/AU2010211251A1/en not_active Abandoned
- 2010-02-02 JP JP2011548590A patent/JP2012516860A/ja not_active Withdrawn
- 2010-02-02 MX MX2011008126A patent/MX2011008126A/es not_active Application Discontinuation
- 2010-02-02 CA CA2751402A patent/CA2751402A1/en not_active Abandoned
- 2010-02-03 US US12/699,451 patent/US8492559B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20100222324A1 (en) | 2010-09-02 |
WO2010089084A1 (de) | 2010-08-12 |
JP2012516860A (ja) | 2012-07-26 |
TW201031665A (en) | 2010-09-01 |
EP2393803A1 (de) | 2011-12-14 |
AR074967A1 (es) | 2011-02-23 |
AU2010211251A1 (en) | 2011-09-29 |
US8492559B2 (en) | 2013-07-23 |
MX2011008126A (es) | 2011-08-17 |
CA2751402A1 (en) | 2010-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2643164T3 (es) | Indol 7-sustituido como inhibidores de Mcl-1 | |
BRPI1008939A2 (pt) | 2-mercaptoquinolina-3-carboxamidas substituídas como moduladores de kncq2/3. | |
BRPI0910585A2 (pt) | indóis como moduladores de receptor de aceticolina nicotínica do subtipo alfa-7 | |
DE602008003116D1 (de) | 8-oxychinolinderivate als modulatoren des bradykinin-b2-rezeptors | |
BRPI0715324A2 (pt) | Composto de indol | |
BRPI0914942A2 (pt) | Compostos de oxindol | |
DK2493858T3 (da) | Androgenreceptor modulerende forbindelser. | |
BR112012006630A2 (pt) | derivados em indol como moduladores dos canais de cálcio ativados para liberação de cálcio (crac) | |
BRPI0912196A2 (pt) | pirazóis trissubstituídos como moduladores do receptor de acetilcolina. | |
BRPI1008949A2 (pt) | Cetoenóis haloalquilmetilenóxi-fenil-substituídos. | |
BRPI0909375A2 (pt) | Moduladores de receptores de quimiocinas | |
BR112012004843A2 (pt) | compostos como moduladores de tirosina cinase | |
HK1149762A1 (en) | Substituted indole derivatives | |
BR112013015234A2 (pt) | derivados fosforosos como moduladores de receptor de quimiocina | |
BRPI0809221A2 (pt) | indol carboxamidas como inibidores de ikk2 | |
BRPI0818338A2 (pt) | Composto de pirimidil indolina | |
BRPI0919898A2 (pt) | 4,5,6,7-tetra-hidrotienopiridinas substituídas como moduladores de kcnq2/3 | |
CU23870B1 (es) | Derivados de ciclopropilamida como moduladores h3 | |
BR112013013037A2 (pt) | derivados de indol como moduladores dos receptores de s1p | |
BRPI1009428A2 (pt) | 3-aminoisoxazolopiridina substituída como moduladores de kcnq2/3 | |
CU23899B1 (es) | Benzotiazoles como moduladores del receptor de grelina | |
BRPI0920247A2 (pt) | benzimidazóis heterocíclicos como moduladores de trpm8. | |
BRPI1009519A2 (pt) | 3-amino-2-mercaptoquinolina substituída como modulador de kcnq2/3. | |
BRPI1008963A2 (pt) | 2-mercapto-3-aminopiridina substituída como moduladores de kcnq2/3 | |
BRPI1008855A2 (pt) | derivados de indol como agentes anticâncer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2373 DE 28-06-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |